Market Tracker

10/20 5:16pm ET

Allergan plc (NYSE:AGN)

188.28
Delayed Data
As of Oct 20
 -0.99 / -0.52%
Today’s Change
182.80
Today|||52-Week Range
256.80
-10.35%
Year-to-Date
My (Brief) Takeaways and Observations
Oct 20 / TheStreet.com - Paid Partner Content
Company News For Oct 19, 2017
Oct 19 / Zacks.com - Paid Partner Content
Analysts Take Action on Health Care Stocks
Oct 20 / GuruFocus News - Paid Partner Content
Conatus Entrusts Keith W. Marshall With Key Management Roles
Oct 19 / Zacks.com - Paid Partner Content
Pharma Stock Roundup: Beat & Raise Quarter from J&J, Allergan Hit by Restasis Ruling
Oct 20 / Zacks.com - Paid Partner Content
Allergan Still Slipping; I'm Not Buying (Yet)
Oct 19 / TheStreet.com - Paid Partner Content
SeaBridge Investment Advisors LLC Buys Seagate Technology PLC, , Steelcase Inc, Sells...
Oct 19 / GuruFocus News - Paid Partner Content
Harvey Investment Co Llc Buys Hexcel Corp, DowDuPont Inc, Duke Energy Corp, Sells All...
Oct 18 / GuruFocus News - Paid Partner Content
Allergan's Hard Fall Is Not Enough of a Reason to Buy
Oct 19 / TheStreet.com - Paid Partner Content
Allergan Shares Are Ready for a 30% Bounce Within Days
Oct 18 / TheStreet.com - Paid Partner Content

Today’s Trading

Previous close189.27
Today’s open190.59
Day’s range187.06 - 192.01
Volume4,755,555
Average volume (3 months)2,547,517
Market cap$62.9B
Dividend yield1.49%
Data as of 4:01pm ET, 10/20/2017

Growth & Valuation

Earnings growth (last year)+281.42%
Earnings growth (this year)+19.95%
Earnings growth (next 5 years)+11.83%
Revenue growth (last year)-3.32%
P/E ratioNM
Price/Sales5.55
Price/Book0.88

Competitors

 Today’s
change
Today’s
% change
AZNAstraZeneca-0.09-0.26%
ABTAbbott Laboratories+0.32+0.57%
LLYEli Lilly and Co+0.87+1.01%
NVONovo Nordisk-0.13-0.26%
Data as of 4:02pm ET, 10/20/2017

Financials

Next reporting dateNovember 1, 2017
EPS forecast (this quarter)$4.05
Annual revenue (last year)$14.6B
Annual profit (last year)$15.0B
Net profit margin-6.46%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
Chairman, President &
Chief Executive Officer
Brenton L. Saunders
Chief Operating Officer
Robert A. Stewart
Corporate headquarters
Dublin, Dublin

Forecasts